Professor and Chairman of Ophthalmology since 1986, Alicante University and Miguel Hernandez University, Spain. Founder and Scientific Director of Vissum Corporation. Author or editor of 89 books, 328 chapters, 500 articles in peer review journals and 36 patents. 95 national and international clinical and research awards. LXIII chair the Academia Ophthalmologica Internationalis and XLIX chair of the European Academy of Ophthalmology, past President of the ISRS/AAO and editorial board member of many peer review journals. The Hirsch factor (h-factor) of Dr Alio is 56 (Scopus). He is the creator and Director of the first online course in refractive surgery from the Miguel Hernandez University entitled Scientific Methodology in Refractive, Cataract and Cornea Surgery.
) Department of Cornea and Refractive Surgery University Miguel Hernandez Alicante Spain
I am the Professor of Ophthalmology at the University of Surrey and a Consultant Ophthalmic Surgeon at the Royal Surrey County Hospital, as well as at St. Mary’s Hospital, London. I have particular expertise in the treatment of retinal and inflammatory ocular diseases. I took a first in medicine at Gonville & Caius College, Cambridge before training as an ophthalmic surgeon at Moorfields Eye Hospital, London. My research training was at the MRC Clinical Sciences Centre and I received a PhD from Imperial College London in 2009. My programme of clinical trials and laboratory research is currently supported by the UK National Institute of Health Research and other grant-awarding bodies.
) Department of Ophthalmology University of Surrey & Royal Surrey County Hospital Surrey UK
Dr. Jyotirmay Biswas is an ophthalmologist who has specialized in uveitis and ophthalmic pathology. He has published 355 articles in peer reviewed journals, 47 chapters in books of ophthalmology. He presented 32 papers in international conferences and 170 papers in national and state conferences. He is reviewer of 36 Journals. He has received 32 awards. He is a member of International Uveitis Study Group. American Uveitis Society and executive council member of International Ocular Inflammation Society. Currently he is working as director of uveitis and ophthalmic pathology departments at Sankara Nethralaya, Chennai.
) Uveitis & Ocular Pathology Department Vision Research Foundation Chennai India
Dr. Saatci is a professor at the Department of Ophthalmology of Dokuz Eylül University,İzmir,Turkey.He completed his residency training in Department of Ophthalmology of Hacettepe University in Ankara in 1989.He worked as a retina fellow with Dr.Richard S.Ruiz at Hermann Eye Center,University of Texas in Houston .Dr Saatci is the member of SİGMA Xi Scientific Society,Euretina,ARVO and American Academy of Ophthalmology.He is in the editorial board of the journals Open Ophthalmology Journal,Retina-Vitreus and Türkiye Klinikleri Oftalmoloji.He served as a reviewer for several well-known journals He is the coauthor of more than 95 peer-reviewed manuscripts published in Pubmed Journals.
) Department of Ophthalmology Dokuz Eylül University Izmir Turkey
(Corneal Diseases) Stephanie L. Watson Department of Ophthalmology Prince of Wales Hospital and Sydney Children’s Hospital Sydney Australia
G. Astrid Limb is a Professor of Retinal Stem Cell Biology and Therapeutics at the UCL Institute of Ophthalmology. Her early postdoctoral work at St Thomas’s Hospital in London highlighted the contribution of pro-inflammatory cytokines to the pathogenesis of retinal inflammatory diseases and led to the publication of highly cited papers in the field. She joined the UCL Institute of Ophthalmology in 1998, where her group was the first to identify the presence of Müller glia with stem cell characteristics in the adult human eye. Her present research is focused on the application of Müller stem cells to cell replacement therapies in various retinal degenerative conditions, including glaucoma, as well as molecular and cellular mechanisms that may be potentially targeted in vivo to promote endogenous regeneration of the retina.
) Institute of Ophthalmology University College London London UK
Dr. Alexander V. Ljubimov is Professor of Biomedical Sciences and Neurosurgery, Director of Eye Program of Regenerative Medicine Institute at Cedars-Sinai Medical Center, and UCLA Professor of Medicine. He authored over 100 papers and is on Editorial Boards of 10 journals. He is a member of Royal Society of Medicine and International Society for Eye Research, and Gold Fellow of the Association for Research in Vision and Ophthalmology. Dr. Ljubimov works in diabetic retinopathy and cancer nanotechnology. He pioneered gene therapy for diabetic corneas, discovered angiogenic role of protein kinase CK2, and is also developing targeted nanosystems for cancer treatment.
Prof. Leopoldo Spadea is an associate clinical professor in ophthalmology, school of medicine, “Sapienza” University of Rome, Italy. Prof. Spadea has previously worked at the University of L'Aquila. He has presented papers at national and international congresses and symposiums and published about 300 scientific publications. In particular, having become an expert in refractive surgery, he has been called upon to present official papers in many international courses and symposiums. Prof. Spadea is an expert on issues concerning corneal topography, excimer laser refractive procedures (PRK and LASIK) and keratoplasty.
) Department of Medico-Surgical Sciences and Biotechnologies Sapienza University of Rome Rome Italy
U. Andley Department of Ophthalmology Washington University School of Medicine St. Louis, MO USA
P.N. Baird Ocular Genetics Unit Centre for Eye Research Australia Melbourne Australia
A.V. Cideciyan Department of Ophthalmology Scheie Eye Institute University of Pennsylvania Philadelphia, PA USA
Tailoi Chan-Ling is Professor of Neurobiology & Visual Science at the University of Sydney. She has made a sustained contribution to the understanding of the cellular processes and molecular cues that drive formation of blood vessels in the retina and choroid during normal development, aging and in disease. She has an ongoing interest in Glial, neuronal and vascular interactions during development of the human retina. Studies have focused on the pathogenetic processes in retinopathy of prematurity (ROP), age-related macular degeneration (AMD), glaucoma, cerebral malaria, and optic neuritis with a recent studies in RPE biology and pathology.
) Department of Anatomy and Histology University of Sydney Sydney Australia
Dr. Gail M. Seigel is a Research Associate Professor at the State University of New York at Buffalo. Dr. Seigel's primary research focus is the study of cancer stem cells and chemoresistance in retinoblastoma. A graduate of Rutgers University (B.S.), and Albany Medical College (Ph.D.), Dr. Seigel joined the SUNY Buffalo faculty in 2001. Dr. Seigel has authored over 75 manuscripts and has received a Cybil Harrington Research.
) Ross Eye Institute University of Buffalo Buffalo, NY USA
Minoru Tomita M.D, PhD is a Director of Minoru Tomita Eye Clinic Ginza in
Tokyo, Japan. He has been visiting professor at Ophthalmology, Wenzhou Medical University and Hebei Provincial Eye Hospital in China. He is also an Editorial member of Journal of Refractive Surgery, BMC Ophthalmology and several other journals.
He has received numerous awards from International Congress and has provided over 100 papers in famous review journal and magazine.
) Department of Ophthalmology Wenzhou Medical College Tokyo Japan
P. Aragona Department of BioMedical Sciences University of Messina Messina Italy
S.K. Bhattacharya Bascom Palmer Eye Institute University of Miami Miami, FL USA
K. Kashiwagi Department of Ophthalmology Faculty of Medicine University of Yamanashi Kofu-city Japan